Product is the result of a partnership with Integrated DNA Technologies, and provides clinical-stage clients with a critical raw material.

Shimadzu's New Nexera UHPLC Series sets industry standard for intelligence, efficiency and design.

Bio-Rad launches of a range of recombinant monoclonal anti-idiotypic antibodies that inhibit the binding of eculizumab (Soliris) to its target, complement C5 protein.

Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing.

Non-exclusive collaboration aims to accelerate adoption and ease of use in processing single-tube sample collection version of the market-leading modern blood test for latent TB detection.

Eppendorf Xplorer plus can now tackle entire columns and rows of a 384-well plate in one single step.

Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids™ Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture.

This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours.

Recognizing the escalating incidence of lung cancer in China, Owlstone Medical and Renji Hospital have a mutual interest in developing and making accessible diagnostics for the early detection of disease.

Alignment of the scope of segments to further strengthen collaboration and leverage synergies.